Informa Releases New Report on Economic Costs of Chinese Delays on Ag-Biotech Approvals

On May 30, Informa’s Agribusiness Consulting Group (Informa) released a study about the impacts of China’s ag-biotech regulatory system on U.S. farmers and the U.S. economy. The report, The Impact of Delays in Chinese Approvals of Biotech Crops, finds that from 2011-2016. Chinese delays resulted in farmers and the broader economy foregoing an estimated $5 billion in farm income growth, nearly 34,000 new jobs, $4.6 billion in wage growth, $7 billion in GDP growth, and $15 billion in business sales. For more information on the report, click here.